s12178-015-9294-7

CACNA1S Antibody (2C5) Summary

    Immunogen
    CACNA1S (NP_000060 1743 a.a. – 1838 a.a.) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. CPRVESSMPEDRKSSTPGSLHEETPHSRSTRENTSRCSAPATALLIQKALVRGGLGTLAADANFIMATGQALGDACQMEPEEVEIMATELLKGREA
    Specificity
    CACNA1S – calcium channel, voltage-dependent, L type, alpha 1S subunit
    Isotype
    IgG2a Kappa
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    CACNA1S
    Purity
    IgG purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        ELISA
    Application Notes
    Antibody reactivity against recombinant protein on ELISA. GST alone used as a negative control.

Packaging, Storage & Formulations

    Storage
    Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
    Buffer
    PBS (pH 7.4)
    Preservative
    No Preservative
    Purity
    IgG purified

Notes

Quality control test: Antibody Reactive Against Recombinant Protein.

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for CACNA1S Antibody (2C5)

      CACH1
      CACN1
      CACNL1A3MHS5
      calcium channel, L type, alpha 1 polypeptide, isoform 3 (skeletal muscle
      Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle
      calcium channel, voltage-dependent, L type, alpha 1S subunit
      Cav1.1
      CCHL1A3
      dihydropyridine receptor
      dihydropyridine-sensitive L-type calcium channel alpha-1 subunit
      HOKPP
      HOKPP1
      hypokalemic periodic paralysis)
      hypoPP
      TTPP1
      voltage-dependent L-type calcium channel subunit alpha-1S
      Voltage-gated calcium channel subunit alpha Cav1.1

Background

This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Beclabuvir

Related Post